Pterjium

Cajucom-Uy H, Tong L, Wong TY, et al. The prevalence of and risk factors for pterjium in an urban Malay population: the Singapore Malay Eye Study (SiMES). British Journal of Ophthalmology. 2010; 94: 977–981.

Fotouhi A, Hashemi H, Khabazkhoob M, et al. Prevalence and risk factors of pterjium and pinguecula: the Tehran Eye Study. Eye. 2009; 23: 1125–1129

Ma K, Xu L, Jie Y, et al. Prevalence of and factors associated with pterjium in adult Chinese: the Beijing Eye Study. Cornea. 2007; 26: 1184–1186.

Viso E, Gude F, Rodríguez-Ares MT. Prevalence of pinguecula and pterjium in a general population in Spain. Eye. 2011; 25: 350–357.

Coroneo MT. Pterjium as an early indicator of ultraviolet insolation: a hypothesis. British Journal of Ophthalmology. 1993; 77: 734–739.

Detorakis ET, Sourvinos G, Spandidos DA. Detection of herpes simplex virus and human papilloma virus in ophthalmic pterjium. Cornea. 2001; 20: 164–167.

Spandidos D, Xinarianos G, Ergazaki M, et al. The presence of herpesviruses in pterjium. International Journal of Oncology. 1994; 5: 749–752.

Chen YF, Hsiao CH, Ngan KW, et al. Herpes simplex virus and pterjium in Taiwan. Cornea. 2008; 27: 311–313.

Otlu B, Emre S, Turkcuoglu P, et al. Investigation of human papillomavirus and Epstein-Barr virus DNAs in pterjium tissue. European Journal of Ophthalmology. 2009; 19: 175–179.

Gallagher MJ, Giannoudis A, Herrington CS, et al. Human papillomavirus in pterjium. British Journal of Ophthalmology. 2001; 85: 782–784.

Tsai YY, Cheng YW, Lee H, et al. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterjium. Molecular Vision. 2005; 11: 50–55

Di Girolamo N, Chui J, Coroneo MT, et al. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Progress in Retinal and Eye Research. 2004; 23: 195–228

Bai H, Teng Y, Wong L, et al. Proliferative and migratory aptitude in pterjium. Histochemistry and Cell Biology. 2010; 134: 527–535.

Safi H, Kheirkhah A, Mahbod M, et al. Correlations between histopathologic changes and clinical features in pterygia. Journal of Ophthalmic and Vision Research. 2016; 11: 153–158.

Tan DT, Chee SP, Dear KB, et al. Effect of pterjium morphology on pterjium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Archives of Ophthalmology.1997; 115: 1235–1240.

Maheshwari S. Pterjium-induced corneal refractive changes. Indian Journal of Ophthalmology. 2007; 55: 383–386.

Johnston SC, Williams PB, Sheppard JD Jr. A comprehensive system for pterjium classification. Investigative Ophthalmology & Visual Science. 2004; 45: 2940

Gumus K, Karakucuk S, Mirza GE, et al. Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate. British Journal of Ophthalmology. 2014;98:796 800

Hovanesian J, Starr C, Vroman D, et al. ASCRS Cornea Clinical Committee. Surgical techniques and adjuvants for the management of primary and recurrent pterygia. Journal of Cataract & Refractive Surgery. 2017;43:405 19.

Kampitak K, Leelawongtawun W, Leeamornsiri S, et al. Role of artificial tears in reducing the recurrence of pterjium after surgery: A prospective randomized controlled trial. Acta Ophthalmologica. 2017;95:e227 9.

Yin D, Lee OL. Risk factors for pterjium recurrence after primary excision. Investigative Ophthalmology & Visual Science. 2011; 52: 3367.

Sánchez-Thorin JC, Rocha G, Yelin JB. Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterjium. British Journal of Ophthalmology. 1998; 82: 661–665.

Kaufman SC, Jacobs DS, Lee WB, et al. Options and adjuvants in surgery for pterjium: a report by the American Academy of Ophthalmology. Ophthalmology. 2013; 120: 201–208.

Clearfield E, Muthappan V, Wang X, et al. Conjunctival autograft for pterjium. Cochrane Database of Systematic Reviews. 2016; 2: CD011349.

Hosal BM, Gürsel E. Mitomycin-C for prevention of recurrent pterjium. Annals of Ophthalmology. 2000; 32: 107–109

Shenasi A, Mousavi F, Shoa-Ahari S, et al. Subconjunctival bevacizumab immediately after excision of primary pterjium: the first clinical trial. Cornea. 2011; 30: 1219–1222.

Yalcin Tok O, Burcu Nurozler A, Ergun G, et al. Topical cyclosporine A in the prevention of pterjium recurrence. Ophthalmologica. 2008; 222: 391–396

Cajucom-Uy H, Tong L, Wong TY, et al. The prevalence of and risk factors for pterjium in an urban Malay population: the Singapore Malay Eye Study (SiMES). British Journal of Ophthalmology. 2010; 94: 977–981.

Fotouhi A, Hashemi H, Khabazkhoob M, et al. Prevalence and risk factors of pterjium and pinguecula: the Tehran Eye Study. Eye. 2009; 23: 1125–1129

Ma K, Xu L, Jie Y, et al. Prevalence of and factors associated with pterjium in adult Chinese: the Beijing Eye Study. Cornea. 2007; 26: 1184–1186.

Viso E, Gude F, Rodríguez-Ares MT. Prevalence of pinguecula and pterjium in a general population in Spain. Eye. 2011; 25: 350–357.

Coroneo MT. Pterjium as an early indicator of ultraviolet insolation: a hypothesis. British Journal of Ophthalmology. 1993; 77: 734–739.

Detorakis ET, Sourvinos G, Spandidos DA. Detection of herpes simplex virus and human papilloma virus in ophthalmic pterjium. Cornea. 2001; 20: 164–167.

Spandidos D, Xinarianos G, Ergazaki M, et al. The presence of herpesviruses in pterjium. International Journal of Oncology. 1994; 5: 749–752.

Chen YF, Hsiao CH, Ngan KW, et al. Herpes simplex virus and pterjium in Taiwan. Cornea. 2008; 27: 311–313.

Otlu B, Emre S, Turkcuoglu P, et al. Investigation of human papillomavirus and Epstein-Barr virus DNAs in pterjium tissue. European Journal of Ophthalmology. 2009; 19: 175–179.

Gallagher MJ, Giannoudis A, Herrington CS, et al. Human papillomavirus in pterjium. British Journal of Ophthalmology. 2001; 85: 782–784.

Tsai YY, Cheng YW, Lee H, et al. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterjium. Molecular Vision. 2005; 11: 50–55

Di Girolamo N, Chui J, Coroneo MT, et al. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Progress in Retinal and Eye Research. 2004; 23: 195–228

Bai H, Teng Y, Wong L, et al. Proliferative and migratory aptitude in pterjium. Histochemistry and Cell Biology. 2010; 134: 527–535.

Safi H, Kheirkhah A, Mahbod M, et al. Correlations between histopathologic changes and clinical features in pterygia. Journal of Ophthalmic and Vision Research. 2016; 11: 153–158.

Tan DT, Chee SP, Dear KB, et al. Effect of pterjium morphology on pterjium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Archives of Ophthalmology.1997; 115: 1235–1240.

Maheshwari S. Pterjium-induced corneal refractive changes. Indian Journal of Ophthalmology. 2007; 55: 383–386.

Johnston SC, Williams PB, Sheppard JD Jr. A comprehensive system for pterjium classification. Investigative Ophthalmology & Visual Science. 2004; 45: 2940

Gumus K, Karakucuk S, Mirza GE, et al. Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate. British Journal of Ophthalmology. 2014;98:796 800

Hovanesian J, Starr C, Vroman D, et al. ASCRS Cornea Clinical Committee. Surgical techniques and adjuvants for the management of primary and recurrent pterygia. Journal of Cataract & Refractive Surgery. 2017;43:405 19.

Kampitak K, Leelawongtawun W, Leeamornsiri S, et al. Role of artificial tears in reducing the recurrence of pterjium after surgery: A prospective randomized controlled trial. Acta Ophthalmologica. 2017;95:e227 9.

Yin D, Lee OL. Risk factors for pterjium recurrence after primary excision. Investigative Ophthalmology & Visual Science. 2011; 52: 3367.

Sánchez-Thorin JC, Rocha G, Yelin JB. Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterjium. British Journal of Ophthalmology. 1998; 82: 661–665.

Kaufman SC, Jacobs DS, Lee WB, et al. Options and adjuvants in surgery for pterjium: a report by the American Academy of Ophthalmology. Ophthalmology. 2013; 120: 201–208.

Clearfield E, Muthappan V, Wang X, et al. Conjunctival autograft for pterjium. Cochrane Database of Systematic Reviews. 2016; 2: CD011349.

Hosal BM, Gürsel E. Mitomycin-C for prevention of recurrent pterjium. Annals of Ophthalmology. 2000; 32: 107–109

Shenasi A, Mousavi F, Shoa-Ahari S, et al. Subconjunctival bevacizumab immediately after excision of primary pterjium: the first clinical trial. Cornea. 2011; 30: 1219–1222.

Yalcin Tok O, Burcu Nurozler A, Ergun G, et al. Topical cyclosporine A in the prevention of pterjium recurrence. Ophthalmologica. 2008; 222: 391–396